Figure 2.

Solicited local symptoms of any grade and grade 3 severities, following two doses of the AS03A-adjuvanted A/Indonesia/5/2005 (H5N1) vaccine, given 21 days apart.

Nagai et al. BMC Infectious Diseases 2010 10:338   doi:10.1186/1471-2334-10-338
Download authors' original image